• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性腮腺多形性腺瘤的临床表现。

Clinical manifestations of recurrent parotid pleomorphic adenoma.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Dankook University, Cheonan, Korea.

出版信息

Clin Exp Otorhinolaryngol. 2009 Dec;2(4):193-7. doi: 10.3342/ceo.2009.2.4.193. Epub 2009 Dec 31.

DOI:10.3342/ceo.2009.2.4.193
PMID:20072694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2804095/
Abstract

OBJECTIVES

This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA), and to identify those factors that affect the development of malignant transformation (MT) from RPA.

METHODS

The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed. The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic multi-nodularity.

RESULTS

Mean age of initial operation in RPA without MT (RPA(-MT)) group was significantly lower than that of primary PA group. Mean age of the revision operation in RPA with MT (RPA(+MT)) group was significantly greater than that of RPA(-MT) group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT and additional recurrence increased significantly with recurrence. In RPA(-MT) group tumor recurrence occurred in 21.4% of patients despite a clear resection margin.

CONCLUSION

The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.

摘要

目的

本研究旨在确认复发性多形性腺瘤(RPA)的临床特征,并确定影响 RPA 发生恶性转化(MT)的因素。

方法

回顾性分析 270 例腮腺多形性腺瘤患者的病历资料。对选定的 23 例患者的病理标本进行组织学亚型和微观多结节性回顾分析。

结果

无 MT 的 RPA(RPA(-MT))组的初次手术平均年龄明显低于原发性多形性腺瘤组。有 MT 的 RPA(RPA(+MT))组的再次手术平均年龄明显高于 RPA(-MT)组。每次再次手术后,从手术到复发的平均间隔时间缩短。随着复发,MT 和额外复发的风险显著增加。尽管切缘清晰,RPA(-MT)组仍有 21.4%的患者发生肿瘤复发。

结论

MT 的危险因素可能是年龄超过 45 岁和多次复发。然而,年轻患者更有复发的风险。明确的切除边界并不能保证 RPA 的治愈,似乎腮腺多形性腺瘤在反复复发后逐渐获得恶性特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/2804095/04b543fcb254/ceo-2-193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/2804095/04b543fcb254/ceo-2-193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b66/2804095/04b543fcb254/ceo-2-193-g001.jpg

相似文献

1
Clinical manifestations of recurrent parotid pleomorphic adenoma.复发性腮腺多形性腺瘤的临床表现。
Clin Exp Otorhinolaryngol. 2009 Dec;2(4):193-7. doi: 10.3342/ceo.2009.2.4.193. Epub 2009 Dec 31.
2
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.多形性腺瘤和复发性多形性腺瘤恶变的比较纵向分析
J Clin Med. 2022 Mar 25;11(7):1808. doi: 10.3390/jcm11071808.
3
Natural history of recurrent pleomorphic adenoma: implications on management.复发性多形性腺瘤的自然病史:对治疗的启示。
Head Neck. 2020 Aug;42(8):2058-2066. doi: 10.1002/hed.26137. Epub 2020 Mar 18.
4
[Management of recurrent pleomorphic adenoma of the parotid gland: analysis of the material of Otolaryngology Department, Medical University of Warsaw between 1998 and 2008].[腮腺复发性多形性腺瘤的治疗:华沙医科大学耳鼻喉科1998年至2008年资料分析]
Otolaryngol Pol. 2010 Jun;64(7):50-4. doi: 10.1016/S0030-6657(10)70010-X.
5
"Unraveling the Tapestry": A Retrospective Exploration of Recurrent Parotid Pleomorphic Adenoma Cases.《解开谜团》:复发性腮腺多形性腺瘤病例的回顾性探索
Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3227-3233. doi: 10.1007/s12070-024-04650-7. Epub 2024 Apr 2.
6
The recurrent pleomorphic adenoma conundrum.复发性多形性腺瘤难题
Curr Opin Otolaryngol Head Neck Surg. 2018 Apr;26(2):134-141. doi: 10.1097/MOO.0000000000000435.
7
Recurrent pleomorphic adenoma of the parotid gland: Institutional experience and review of the literature.腮腺复发性多形性腺瘤:机构经验及文献综述
J Surg Oncol. 2016 Nov;114(6):714-718. doi: 10.1002/jso.24392. Epub 2016 Jul 29.
8
Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.复发性多形性腺瘤中的血管生成和淋巴管生成微血管密度
J Oral Pathol Med. 2009 Sep;38(8):623-9. doi: 10.1111/j.1600-0714.2009.00794.x. Epub 2009 Jun 25.
9
Repeatedly recurring pleomorphic adenoma: a therapeutic challenge.复发性多形性腺瘤:一项治疗挑战。
Acta Otorhinolaryngol Ital. 2019 Jun;39(3):156-161. doi: 10.14639/0392-100X-2307.
10
Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.研究复发性多形性腺瘤的组织病理学、形态学和免疫组织化学特征:预测多形性腺瘤复发的尝试。
J Oral Pathol Med. 2011 Apr;40(4):352-8. doi: 10.1111/j.1600-0714.2010.00956.x. Epub 2010 Oct 24.

引用本文的文献

1
"Unraveling the Tapestry": A Retrospective Exploration of Recurrent Parotid Pleomorphic Adenoma Cases.《解开谜团》:复发性腮腺多形性腺瘤病例的回顾性探索
Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3227-3233. doi: 10.1007/s12070-024-04650-7. Epub 2024 Apr 2.
2
Estrogen, Progesterone and Androgen Receptor in Primary and Recurrent Pleomorphic Salivary Adenomas.原发性和复发性多形性腺瘤中的雌激素、孕激素和雄激素受体。
Asian Pac J Cancer Prev. 2023 May 1;24(5):1731-1735. doi: 10.31557/APJCP.2023.24.5.1731.
3
Common Tumor in an uncommon location: Pleomorphic Adenoma of nasal cavity - a case Report.

本文引用的文献

1
Clinical aspects of tumors of the major salivary glands.大唾液腺肿瘤的临床特征
Cancer. 1954 Jul;7(4):637-59. doi: 10.1002/1097-0142(195407)7:4<637::aid-cncr2820070403>3.0.co;2-#.
2
Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5-year mean follow-up study of histologically marginal excisions.腮腺多形性腺瘤边缘切除:复发风险因素及处理。一项对组织学边缘切除进行12.5年平均随访的研究。
Clin Otolaryngol Allied Sci. 2003 Jun;28(3):262-6. doi: 10.1046/j.1365-2273.2003.00704.x.
3
Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
罕见部位的常见肿瘤:鼻腔多形性腺瘤——一例报告
Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):947-950. doi: 10.1007/s12070-022-03446-x. Epub 2023 Feb 4.
4
Clinico-histopathological review of 255 patients who underwent parotidectomy for pleomorphic adenoma: a 10-year retrospective study-a proposal for an optimal diagnostic and therapeutic algorithm for patients with recurrent pleomorphic adenoma.255 例行腮腺切除术治疗多形性腺瘤患者的临床病理回顾:10 年回顾性研究——为复发性多形性腺瘤患者提出最佳诊断和治疗方案的建议。
Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3329-3335. doi: 10.1007/s00405-023-07897-y. Epub 2023 Mar 6.
5
Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.多形性腺瘤和复发性多形性腺瘤恶变的比较纵向分析
J Clin Med. 2022 Mar 25;11(7):1808. doi: 10.3390/jcm11071808.
6
Pleomorphic adenoma of the maxillary sinus with orbital extension presenting with exophthalmos: a case report.上颌窦多形性腺瘤伴眼眶侵犯致眼球突出:一例报告
AME Case Rep. 2021 Oct 25;5:39. doi: 10.21037/acr-21-31. eCollection 2021.
7
Radiation Therapy After Surgical Resection Improves Outcomes for Patients With Recurrent Pleomorphic Adenoma.手术切除后进行放射治疗可改善复发性多形性腺瘤患者的预后。
Adv Radiat Oncol. 2021 Mar 2;6(3):100674. doi: 10.1016/j.adro.2021.100674. eCollection 2021 May-Jun.
8
Repeatedly recurring pleomorphic adenoma: a therapeutic challenge.复发性多形性腺瘤:一项治疗挑战。
Acta Otorhinolaryngol Ital. 2019 Jun;39(3):156-161. doi: 10.14639/0392-100X-2307.
9
Stationary facial nerve paresis after surgery for recurrent parotid pleomorphic adenoma: a follow-up study of 219 cases in Denmark in the period 1985-2012.复发性腮腺多形性腺瘤手术后的静止性面神经麻痹:丹麦1985 - 2012年219例病例的随访研究
Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3313-9. doi: 10.1007/s00405-016-3921-9. Epub 2016 Feb 12.
10
Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.涎腺复发性多形性腺瘤中Rb信号通路的失调
Virchows Arch. 2015 Sep;467(3):295-301. doi: 10.1007/s00428-015-1804-x. Epub 2015 Jul 9.
腮腺复发性多形性腺瘤患者中雌激素受体、孕激素受体、胰岛素样生长因子受体-1及MIB-1的表达
Cancer. 2002 Apr 15;94(8):2211-6. doi: 10.1002/cncr.10445.
4
Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: a clinical analysis of 52 patients.腮腺复发性多形性腺瘤的外科治疗:52例临床分析
Head Neck. 2001 Apr;23(4):311-6. doi: 10.1002/hed.1036.
5
Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases.临床良性腮腺肿瘤:在特定病例中,局部解剖作为浅叶腮腺切除术的替代方法。
Ann R Coll Surg Engl. 1999 Sep;81(5):299-301.
6
Treatment of recurrent pleomorphic adenomas of the parotid gland.腮腺复发性多形性腺瘤的治疗
Otolaryngol Head Neck Surg. 1999 Nov;121(5):539-42. doi: 10.1016/S0194-5998(99)70053-7.
7
Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study.涎腺多形性腺瘤:前瞻性临床病理及流式细胞术研究
Head Neck. 1999 Oct;21(7):652-6. doi: 10.1002/(sici)1097-0347(199910)21:7<652::aid-hed10>3.0.co;2-e.
8
[Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands].[涎腺复发性和非复发性多形性腺瘤中的增殖活性]
Laryngorhinootologie. 1999 Feb;78(2):77-80. doi: 10.1055/s-2007-996835.
9
Metastasizing pleomorphic adenoma: a report of three cases.转移性多形性腺瘤:三例报告
Eur J Surg Oncol. 1998 Oct;24(5):452-5. doi: 10.1016/s0748-7983(98)92651-8.
10
Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up.腮腺复发性多形性腺瘤:临床评估与长期随访
Br J Oral Maxillofac Surg. 1998 Feb;36(1):48-51. doi: 10.1016/s0266-4356(98)90748-3.